Court Opinion

ID: 799072
Source: CourtListenerOpinion
Date Created: 2012-05-01 18:03:59+00
Date Added: 2024-06-11T13:33:11.830310
License: Public Domain

United States Court of Appeals
           for the Federal Circuit
                             ______________________

                                     May 1, 2012

                                   ERRATA
                             ______________________

                         Appeal Nos. 2011-1399, -1409

   IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-
               RELEASE CAPSULE PATENT LITIGATION
      ---------------------------------------------------------------------------------
        EURAND, INC., CEPHALON, INC., and ANESTA AG,

                                                Plaintiffs-Cross Appellants,

                                           v.

        MYLAN PHARMACEUTICALS INC. and MYLAN INC.,

                                                Defendants-Appellants,

                                          and

 BARR LABORATORIES, INC., TEVA PHARMACEUTICALS USA,
   INC., and TEVA PHARMACEUTICAL INDUSTRIES LTD.,

                                         Defendants-Appellees.
                             ______________________

                             Decided: April 16, 2012
                              Precedential Opinion
                             ______________________

Please make the following additions:

Page 2, Of counsel on the brief for plaintiff-cross appellant was Tryn T.
Stimart, Cooley Godward Kronish LLP, of Washington, DC.

Robert L. Byer, Duane Morris LLP, of Pittsburg, Pennsylvania, for
amici curiae Gregory Dolin and Robert C. Kahrl. With him on the
brief were Kristina Caggiano and Elese Hanson.